Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2015 08:31 ET | Source: iBio, Inc.

Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting

NEW YORK, NY--(Marketwired - Nov 19, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, announced the presentation at...
October 27, 2015 08:31 ET | Source: iBio, Inc.

iBio European Protein Expression Patent Emerges From Opposition Period

NEW YORK, NY--(Marketwired - Oct 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced receipt of...
September 30, 2015 08:31 ET | Source: iBio, Inc.

New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio

NEW YORK, NY--(Marketwired - Sep 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced a notice of...
September 21, 2015 08:31 ET | Source: iBio, Inc.

iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides

NEW YORK, NY--(Marketwired - Sep 21, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, today announced further...
September 09, 2015 08:31 ET | Source: iBio, Inc.

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

NEW YORK, NY--(Marketwired - Sep 9, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, announced the award of a...
August 11, 2015 08:31 ET | Source: iBio, Inc.

iBio to Receive US Patent for Influenza Therapeutic

NEW YORK, NY--(Marketwired - Aug 11, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, received notice that its...
June 08, 2015 08:31 ET | Source: iBio, Inc.

Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland

NEW YORK, NY--(Marketwired - Jun 8, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, announced that three invited...
May 04, 2015 08:31 ET | Source: iBio, Inc.

Vaccine Improvement Patent Awarded to iBio

NEW YORK, NY--(Marketwired - May 4, 2015) - iBio, Inc. (NYSE MKT: IBIO) a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a...
April 27, 2015 08:31 ET | Source: iBio, Inc.

iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics

NEWARK, DE--(Marketwired - Apr 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio's...
March 30, 2015 08:31 ET | Source: iBio, Inc.

iBio European Plague Vaccine Patent Emerges From Opposition Period

NEWARK, DE--(Marketwired - Mar 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), today announced it received notice from the European Patent Office that the opposition period expired for a bio-defense...